Growth capital
Sony Innovation Fund leads Series D for India’s Zoomcar
Indian self-driving rental platform Zoomcar has raised $30 million in Series D funding with a contribution from a Sony-branded fund managed by Innovation Growth Ventures.
4Q analysis: On trend
The last three months of 2019 were consistent with the preceding nine as pan-regional fundraising remained weak and exits continued to disappoint. Only investment rebelled against the status quo
BlackRock backs Australia hotel booking platform SiteMinder
BlackRock has made an equity investment in Australia-based hotel booking platform SiteMinder that values the company at about A$1.1 billion ($760 million).
Deal focus: Baibu broadens its fabric scope
VC-backed Chinese B2B fabrics trading platform Baibu is making the transition from online marketplace to cloud-based consolidator of the country's fragmented factories
Discipline, operations key to PE success in China - DCP's Liu
Private equity investors in China should prioritize discipline on valuations and operational capabilities rather than spend their time worrying about macroeconomic risks, according to David Liu, chairman and founder of DCP Capital.
Accel-KKR invests Australia workforce software player
Accel-KKR, a US-based private equity firm created by Accel Partners and KKR, has invested A$28 million ($19.3 million) in Australian workforce management software provider Pegasus.
Tiger Global commits $300m to India's Byju's
Tiger Global Management has led a $300 million funding round for India-based online learning platform Byju’s, joining an investor roster that already includes Tencent Holdings, General Atlantic, Naspers Ventures, Sequoia Capital India, and the Chan...
India's Zomato taps Ant Financial again for $150m
Ant Financial has invested $150 million in Indian restaurant discovery and food delivery platform Zomato, pushing the company's valuation to $3 billion.
Zhiyun raises $144m for chronic disease management platform
Zhiyun Health, a Chinese online healthcare services provider, has raised more than RMB1 billion ($144 million) across two rounds. It describes the investment as the largest private funding event globally in the chronic disease management space.
China's Transcenta secures $100m funding round
Transcenta Holding, a Chinese biotech company formed last year through the merger of MabSpace Bioscience and Hangzhou Just Biotherapeutics (HJB), has raised $100 million in an extended Series B funding round.
Chinese drug developer wins General Atlantic backing
General Atlantic has led a $69 million Series D round of funding for Adagene, a Chinese drug developer with one cancer treatment currently in phase one clinical trials in China and the US.
Everstone backs US, India-based generics developer
The Everstone Group has agreed to invest $50 million in Slayback Pharma, a developer of generic and specialty drugs with a presence in India and the US.
India's True North makes $75m biosimilars bet
True North has invested INR5.36 billion ($74.6 million) in the biosimilars business of India-listed pharmaceuticals giant Biocon.
Chinese genetic testing player secures $115m round
Geneseeq, a Chinese genetic testing company that focuses on treatments for cancer, has raised RMB800 million ($115 million) in a funding round led by state-owned China Reform Holding Corporation.
SoftBank Vision Fund invests $275m in India's Lenskart
SoftBank Vision Fund has led a Series G round of more than $275 million for Lenskart, an Indian omnichannel eyewear retailer, facilitating exits for several early investors.
Hong Kong's WeLab secures $156m Series C
WeLab, a Hong Kong financial technology start-up that abandoned plans for an IPO approximately 12 months ago, has raised $156 million in a new private funding round.
China's Sailing exits as US GP backs Maldives resort chain
Chinese cross-border private equity firm Sailing Capital has exited its position in Soneva, a Thailand-based luxury hotel operator known for its Maldives resorts, following the sale of a significant minority stake to US-based KSL Capital Partners.
Taiwan's Appier gets $80m Series D
Appier, a Taiwan-headquartered start-up that develops artificial intelligence-enabled platforms intended to help corporates optimize advertising campaigns, has raised $80 million in Series D funding.
MBK, Mirae buy stake in Asia assets of Korea's CJ CGV
MBK Partners and Mirae Asset Daewoo Private Equity have agreed to pay KRW333.6 billion ($286 million) for a minority position in the China and Southeast Asia assets of Korean cinema chain operator CJ CGV.
CDC backs Nepalese internet service provider
CDC Group has made its first equity investment in Nepal with a NPR1.35 billion ($12 million) commitment to WorldLink, the country’s largest private sector internet service provider.
Chinese online-offline retailer KK Group achieves unicorn status
Chinese retailer KK Group - formerly known as KK Guan - has raised a $100 million Series D led by an Alibaba Group-backed fund. N5 Capital, Matrix Partners China and Black Algae Capital all re-upped.
ARQ Capital backs Philippines dialysis business
ARQ Capital, a Philippines-based GP focused on the local small to medium-sized enterprise (SME) sector, has invested an undisclosed sum in dialysis clinic operator Medline.
Australia's AirTree closes third fund at $188m
Australia’s AirTree Ventures has closed its third fund at A$275 million ($188 million) with substantial contributions from local superannuation funds.
China apartment rental platforms: Illogical letting
Qingke, a Chinese long-term apartment rental operator, is looking to go public at a time when many of its peers are going out of business. Pursuing scale at the expense of sustainability is the core problem